United States Antimony에 대한 매도 수량은 투자자에게 United States Antimony의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

United States Antimony (AMEX:UAMY) 주식, 공매도 수량 보고

United States Antimony

United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.

Commodities

UAMY

2024년 5월 15일 주요 뉴스: U.S. 안티모니: U.S. 안티모니(Antimony) (AMEX:UAMY)는 판매 비용 증가 감소로 인해 매출이 28% 증가한 283만 달러, 총 이익이 108% 증가한 1분기 결과를 보고했다. 

수요일 주요 광업 뉴스: U.S. 안티모니, 피드몬트 리튬, 페로글로브, 솔리타리오 리소스

United States Antimony Corporation Common Stock

United States Antimony Corp

As of Aug 19, 2024, three stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Aspen Aerogels Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>)</h3>
<ul>
<li>On Aug. 7, Aspen Aerogels reported better-than-expected second-quarter revenue results. &#8220;This quarter&#8217;s results demonstrate the significant operating leverage of our business model as we continue to utilize a higher percentage of our current capacity and effectively execute our strategy,&#8221; commented Don Young, Aspen&#8217;s President and CEO. The company's stock gained around 35% over the past five days and has a <a href="https://www.benzinga.com/quote/ASPN">52-week high of $31.74</a>.</li>
<li>RSI Value: 73.40&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>ASPN Price Action: Shares of Aspen Aerogels gained 22.6% to close at $29.92 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Anglogold Ashanti PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AU#NYSE">AU</a>)</h3>
<ul>
<li>On Aug. 6, AngloGold Ashanti reported a year-over-year increase in H1 financial results. &#8220;These results show the hard work that&#8217;s been done to improve the fundamentals of our business, to drive productivity benefits and manage costs to ensure we capture the benefit of stronger gold prices,&#8221; CEO Alberto Calderon said. &#8220;We expect to deliver an even stronger second-half performance.&#8221; The company's stock gained around 12% over the past month and <a href="https://www.benzinga.com/quote/AU">has a 52-week high</a> of $31.65.</li>
<li>RSI Value: 70.53</li>
<li>AU Price Action: Shares of Anglogold Ashanti gained 3.6% to close at $31.47 on Friday.</li>
</ul>
<h3 class="wp-block-heading">United States Antimony Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAMY#NYSE">UAMY</a>)</h3>
<ul>
<li>On Aug. 9, the company said revenues for the first six months of 2024 increased 26%, or $1.169 million, to $5.6 million, compared to the first six months of 2023. The company's stock gained around 71% over the past month and has a <a href="https://www.benzinga.com/quote/UAMY">52-week high</a> of $0.57.</li>
<li>RSI Value: 84.97</li>
<li>UAMY Price Action: Shares of United States Antimony gained 11.6% to close at $0.53 on Friday.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/08/40420521/jim-cramer-recommends-buying-clorox-ceo-has-done-remarkable-job">Jim Cramer Recommends Buying Clorox: &#8216;CEO Has Done Remarkable Job&#8217;</a></li>
</ul>

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

ASPN

Top 3 Materials Stocks That May Collapse In Q3

United States Antimony Corporation Acquires 100% Ownership Of 97 Mining Claims And 3 Leases In Ontario's Sudbury District, Targeting Critical Minerals Cobalt, Nickel, Copper, And Bismuth Amid Canada's Billion-Dollar Plan To Boost Critical Minerals Sector

<h3 class="wp-block-heading">U.S. Antimony</h3>
U.S. Antimony (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UAMY#AMEX">UAMY</a>) reported its first-quarter (Q1) results with revenues rising 28% to $2.83 million and a 108% increase in gross profit due to a lower rise in sales costs.&nbsp;
<ol>
<li></li>
</ol>
<ul>
<li>Operating expenses increased by 183%, partly due to non-cash stock compensation and net income for Q1 was $86k.&nbsp;</li>
<li>The company ceased its Mexico operations, reduced overhead and shifted to a &#8220;Discontinued Operation.&#8221;&nbsp;</li>
<li>Cash position improved to $11.94 million and chairman and co-CEO Gary C. Evans called the quarter a turning point, emphasizing improved U.S. operations and a strong cash position.</li>
</ul>
Also Read:<a href="https://www.benzinga.com/topic/mining"> </a><a href="https://www.benzinga.com/news/large-cap/24/05/38826363/anglo-american-expedites-plan-to-divest-de-beers-other-assets-after-rebuffing-bhp-takeover-bid">Anglo American Expedites Plan To Divest De Beers, Other Assets After Rebuffing BHP Takeover Bid</a>
<h3 class="wp-block-heading">Piedmont Lithium</h3>
Piedmont Lithium (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLL#NASDAQ">PLL</a>) announced new high-grade lithium zones at North American Lithium (NAL) in Quebec, jointly owned by Piedmont (25%) and Sayona Mining Limited (75%).&nbsp;
<ol start="2">
<li></li>
</ol>
<ul>
<li>The 2023 drill program suggests a potential mineral resource upgrade and mine life extension, discovering thick spodumene-bearing pegmatites beyond current operations.&nbsp;</li>
<li>NAL, which restarted production in March 2023, has consistently set record production volumes.&nbsp;</li>
<li>President and CEO Keith Phillips highlighted the potential for resource upgrades, emphasizing NAL&#8217;s strategic importance and exciting possibilities for extended mine life and increased production.</li>
</ul>
<h3 class="wp-block-heading">Ferroglobe</h3>
Ferroglobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSM#NASDAQ">GSM</a>) reported Q1 financial results with an adjusted EBITDA of $25.8 million. The company achieved a positive net cash position for the first time.&nbsp;
<ol start="3">
<li></li>
</ol>
<ul>
<li>The company's gross debt hit an all-time low of $81 million. It initiated and announced quarterly cash dividends of 1.3 cents per share.&nbsp;</li>
<li>A $200 million stock buyback program over five years was also approved, pending a shareholder vote in June 2024.&nbsp;</li>
<li>French operations were fully restarted on April 1. The company is applying for a permit to expand U.S. silicon metal production and signed an MOU with Coreshell, followed by a post-quarter investment after positive lab test results.</li>
</ul>
<h3 class="wp-block-heading">Solitario Resources</h3>
Solitario Resources (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/XPL#AMEX">XPL</a>) discovered three new high-grade gold zones – Holland, Top Dollar and Wildcat – at its Golden Crest project.&nbsp;
<ol start="4">
<li></li>
</ol>
<ul>
<li>Reconnaissance sampling revealed gold values up to 57.9 grams per ton (gpt).&nbsp;</li>
<li>The zones span a four-square-kilometer area between Downpour and Sleeping Beauty targets, with 203 samples collected, including 27 samples exceeding one gpt gold.&nbsp;</li>
<li>President and CEO Chris Herald highlighted these as some of the highest-grade initial samples at Golden Crest and anticipates the upcoming drilling program starting in June.</li>
</ul>
Now Read:<a href="https://www.benzinga.com/"> </a><a href="https://www.benzinga.com/news/24/05/38791907/australia-injects-374m-into-critical-minerals-exploration-weve-got-some-huge-advantages">Australia Injects $374M Into Critical Minerals Exploration: &#8216;We&#8217;ve Got Some Huge Advantages&#8217;</a>
Benzinga Mining is the bridge between mining companies and retail investors. Reach out to <a href="mailto:licensing@benzinga.com">licensing@benzinga.com</a> to get connected with the Benzinga community!

US Antimony Halts Mexico Operations; Piedmont Lithium New Discoveries; Ferroglobe Sees Positive Net Cash And More: Wednesday's Top Mining Stories

Top Stories for March 11, 2024:
1. United States Antimony Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAMY#NYSE">UAMY</a>) announced the immediate discontinuation of all <a href="https://www.benzinga.com/topic/mining">operations in Latin America</a>, including the sale or closure of its U.S. Antimony de Mexico subsidiary.
This action will affect the company's Madero smelter and the Puerto Blanco mining facility due to their long-standing negative cash flow and lack of future profitability.&nbsp;
The move aims to improve cash flow for its remaining business in Thompson Falls, Montana.&nbsp;
The company plans to sell or lease the affected assets and has begun looking for buyers or lessees. The financial impact of these actions is currently unclear.&nbsp;
United States Antimony will retain its Los Juarez mining claims, which have significant exploration potential but no active operations.
Chairman and Co-CEO Gary C. Evans said, "Based upon a thorough review of historical financial numbers of our Mexican operations&#8230; it became painfully obvious that these operations have always been unprofitable.… Antimony continues to be a &#8216;Critical Mineral&#8217; on the U.S. Government&#8217;s Defense and Energy lists of needs. Our existing operation in Thompson Falls is profitable and continues to operate efficiently."
Also Read: <a href="https://www.benzinga.com/etfs/sector-etfs/24/03/37568022/gold-etfs-diverge-from-spot-prices-record-ninth-consecutive-month-of-outflows">Gold ETFs Diverge From Spot Prices: Record Ninth Consecutive Month Of Outflows</a>
2. United States Steel Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) <a href="https://www.ussteel.com/newsroom/-/blogs/u-s-steel-makes-strategic-investment-in-pittsburgh-based-autonomous-warehousing-pioneer-freespace-robotics?_com_liferay_blogs_web_portlet_BlogsPortlet_redirect=https%3A%2F%2Fwww.ussteel.com%3A443%2Fnewsroom%3Fp_p_id%3Dcom_liferay_blogs_web_portlet_BlogsPortlet%26p_p_lifecycle%3D0%26p_p_state%3Dnormal%26p_p_mode%3Dview%26_com_liferay_blogs_web_portlet_BlogsPortlet_cur%3D1%26_com_liferay_blogs_web_portlet_BlogsPortlet_delta%3D20">invested</a> in Freespace Robotics, a Pittsburgh-based company specializing in innovative robotic storage and retrieval systems for global warehouses. 
The company&#8217;s autonomous storage system uses robots for efficient handling and storage of goods.&nbsp;
Funds from U.S. Steel will be used for pilot programs, establishing a manufacturing base in the region and hiring local talent and expanding its team.&nbsp;
U.S. Steel's Director of Strategy and Corporate Development, Jim Cook, will also join Freespace Robotics' Board of Directors.
Senior Vice President and Chief Technology Officer Christian Gianni stated, "Investing in Freespace Robotics is another way we're promoting innovation while supporting the regional economy and its workforce…we&#8217;re doubling down on the region because we believe in its potential to be a force for innovation in the U.S. and beyond."
The details of the investment were not disclosed.
3. Benchmark analyst Nathan Martin maintained Ramaco Resources (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/METC#NASDAQ">METC</a>) with a Buy and <a href="https://www.benzinga.com/quote/METC/analyst-ratings">raised his price target</a> from $20 to $27.
4. Seaport Global analyst Martin Englert <a href="https://www.benzinga.com/quote/WS/analyst-ratings">initiated coverage</a> on Worthington Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WS#NYSE">WS</a>) with a Neutral rating.
Now Read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37569351/gold-rises-to-all-time-highs-marks-longest-winning-streak-since-july-2000-driven-by">Gold Rises To All-Time Highs: Rate Cut Anticipation Drives Longest Winning Streak Since July 2000</a>
Image created using artificial intelligence with Midjourney.

Price Target

Topics

Analyst Ratings

METC

US Antimony Halts Latin American Operations; US Steel Invests In Freespace Robotics And More: Monday's Top Mining Stories

United States Antimony Corporation ("USAC"), (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAMY#NYSE">UAMY</a>) announced today changes with the executive level management of the Company. These executive management changes are effective March 1, 2024.
Mr. John (Gus) Gustavsen has been appointed President of the Company's Antimony Division and he has relinquished his title as CEO of U.S. Antimony Corporation. The Company is continuing its operations and business activities in Thompson Falls, Montana, where Mr. Gustavsen resides. This location is the only North American producer of Antimony products, including antimony oxide, antimony metal, and antimony tri-sulfide. Antimony is used in munitions (lead hardening for bullets and primer production), flame retardants, semiconductors, and batteries. Mr. Gustavsen is considered one of the nation's leading experts in the field of Antimony.
The Board of Directors has asked two existing board members to serve as Co-CEOs while the company continues to streamline its business, rid itself of unprofitable operations, and pursue certain expansion efforts which may include acquisitions. The new positions are as follows:
Joe Bardswich - Co-CEO &amp; Director
Gary C. Evans - Co-CEO &amp; Chairman of the Board
Neither Mr. Bardswich nor Mr. Evans are receiving any cash compensation for their new roles at the Company. However, the Board has granted them time-based equity compensation, which was awarded at the Company's stock price on the grant date.

Management

U.S. Antimony Announces Executive Management Changes; Mr. John (Gus) Gustavsen Appointed As President, Relinquished Title Of CEO; Board Of Directors Has Asked Two Existing Board Members To Serve As Co-CEOs, Joe Bardswich And Gary C. Evans, Effective March 1, 2024

Top Stories for Jan. 29, 2024:
1. TD Cowen downgraded Piedmont Lithium Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pll#NASDAQ">PLL</a>) from Outperform <a href="https://www.benzinga.com/quote/PLL/analyst-ratings">to Market Perform.</a>
2. President Joe Biden&#39;s economic advisors signaled a commitment <a href="https://www.benzinga.com/markets/equities/24/01/36815501/bidens-advisors-signal-labor-focus-in-nippon-steels-united-states-steel-deal-amid-election-year-">to protecting union jobs</a> and U.S. steel manufacturing, implying that U.S. Steel Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/x#NYSE">X</a>) would need to increase its support for organized labor for its $14.1 billion deal with Nippon Steel Corporation to be finalized.
On a related note, former Louisiana Attorney General&nbsp;Charles C.&nbsp;Foti, Jr., Esq. and the law firm of Kahn Swick &amp; Foti, LLC are investigating the proposed sale of United States Steel.
Under the terms of the transaction, U.S. Steel shareholders will receive $55 in cash per share, and the investigation will determine whether that deal is adequate or undervalues the company.
3. United States Antimony Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uamy#NYSE">UAMY</a>) appointed Jeffrey Fink as its Vice President and General Manager of its Bear River Zeolite mining operation.
Chairman of the Board Gary C. Evans said, &quot;Management and the Board of Directors at UAMY completed an exhaustive search over the last several months for a new general manager of our Bear River Zeolite mining operation located in Preston, Idaho. We believe this property has significant potential for increased production volumes.&quot;
&quot;We are very pleased to announce today that this mission has been accomplished with the hiring of Jeffrey (Jeff) Fink as our new Vice President and General Manager of BRZ&hellip;Based upon his past experience, his energetic enthusiasm, his passion for safety and profit-minded drive for continuous process manufacturing, we are anticipating substantial improvements (including product supply for our customers) at BRZ under his watch,&quot; he added.
4. American Battery Technology Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abat#NASDAQ">ABAT</a>) will participate in the Bloomberg New Energy Finance Summit in San Francisco from Jan. 30 to Jan. 31.
CEO Ryan Melsert will join a &quot;Can Battery Recycling Solve Supply Chain Challenges&#39;&#39; panel to discuss industry challenges, including the domestic scaling of battery recycling capacity.
Now Read:&nbsp;<a href="https://www.benzinga.com/government/24/01/36832252/short-seller-does-victory-lap-after-amazon-deal-dies-what-happened-to-irobot">Short Seller Does Victory Lap After Amazon Deal Dies &mdash; What Happened To iRobot?</a>
Photo: Shutterstock

Penny Stocks

Small Cap

ABAT

TD Cowen Downgrades Piedmont; Biden On US Steel Deal; American Battery At Bloomberg Summit And More

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/"> Benzinga Pro</a>.
Here&rsquo;s the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3>United States Antimony Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uamy#NYSE">UAMY</a>)</h3>
<ul>
<li>U.S. Antimony, during August, announced appointment of Gary C. Evans as Chairman of its Board of Directors. The company&rsquo;s stock has a <a href="https://www.benzinga.com/quote/UAMY">52-week low of $0.24 </a>.</li>
<li>RSI Value: 29.71</li>
<li>UAMY Price Action: Shares of United States Antimony fell 2% to close at $0.2550 on Tuesday.</li>
</ul>
<h3>Northern Technologies International Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntic#NASDAQ">NTIC</a>)</h3>
<ul>
<li>Northern Technologies posted weaker-than-expected earnings for the fourth quarter. &ldquo;Fiscal 2023 marked NTIC&rsquo;s third year of consecutive record sales, despite the economic challenges growing in both Europe and China, as well as rising interest rates in the U.S. Our continued sales growth success demonstrates the increasing value we provide our global customers as well as the efficacy of our strategic focus on diversifying our products, end markets and geographies,&rdquo; said G. Patrick Lynch, President and CEO of NTIC. It <a href="https://www.benzinga.com/quote/NTIC"> has a 52-week low </a> of $10.10.</li>
<li>RSI Value: 24.22</li>
<li>NTIC Price Action: Shares of Northern Technologies International fell 4.2% to close at $11.21 on Tuesday.</li>
</ul>
<h3>Gulf Resources, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gure#NASDAQ">GURE</a>)</h3>
<ul>
<li>The company posted a loss for the third quarter. &ldquo;We are vigilantly monitoring events in the Middle East, recognizing that any disruptions in the Dead Sea region could suddenly alter market dynamics. Looking ahead, we envision returning to profitability in the forthcoming quarters,&rdquo; Mr. Liu Xiaobin, CEO said. The company&rsquo;s stock has a 52-week <a href="https://www.benzinga.com/quote/GURE"> low of $1.44.</a></li>
<li>RSI Value: 20.59</li>
<li>GURE Price Action: Shares of Gulf Resources fell 4.2% to close at $1.4650 on Tuesday.</li>
</ul>
<h3>Millennium Group International Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgih#NASDAQ">MGIH</a>)</h3>
<ul>
<li>The company&rsquo;s stock lost around 41% over the past month. The company&rsquo;s 52-week low is $0.89.</li>
<li>RSI Value: 24.10</li>
<li>MGIH Price Action: Shares of Millennium Group International fell 1.4% to close at $0.9660 on Tuesday.</li>
</ul>
<h3>Sibanye Stillwater Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sbsw#NYSE">SBSW</a>)</h3>
<ul>
<li>B of A Securities, last month, downgraded Sibanye Stillwater from Neutral to Underperform. The company <a href="https://www.benzinga.com/quote/SBSW"> has a 52-week low </a> of $4.00.</li>
<li>RSI Value: 24.44</li>
<li>SBSW Price Action: Shares of Sibanye Stillwater fell 17.9% to close at $4.27 on Tuesday.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/news/earnings/23/11/35911235/deere-nvidia-and-3-stocks-to-watch-heading-into-wednesday"> Deere, Nvidia And 3 Stocks To Watch Heading Into Wednesday </a>

Long Ideas

GURE

MGIH

NTIC

SBSW

Top 5 Materials Stocks That May Rocket Higher In November

&nbsp;United States Antimony Corporation (&quot;USAC&quot;), (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAMY#NYSE">UAMY</a>) announced today the decision of John (Gus) Gustavsen on July 28, 2023, to step down from his position as Chairman and a board member for personal reasons. Mr. Gustavsen will remain in his current position as Chief Executive Officer of the Company. Additionally, the Company announces the appointment of Gary C. Evans, effective July 29, 2023, as Chairman of its Board of Directors. Mr. Evans previously served as Lead Director of the Company. He will continue at this time to be deemed &quot;Independent.&quot;

U.S. Antimony Announces Appointment Of Gary C. Evans As Chairman Of Its Board Of Directors; John Gustavsen Resigns From Board And Retains His Position As CEO

&nbsp;United States Antimony Corporation (&quot;USAC&quot;), (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAMY#NYSE">UAMY</a>) is pleased to announce the appointment of Richard (Rick) R. Isaak, age 55, as Senior Vice President and Chief Financial Officer effective today. He succeeds Kelly J. Stopher who previously served as the Company&#39;s contract Chief Financial Officer. Mr. Stopher will remain as a consultant during the transition period.
Rick started his career at Ernst &amp; Young as a CPA in the assurance and advisory business services area for 12 years with extensive experience with managing public company audits and SEC reporting primarily for large, multinational companies. After Ernst &amp; Young, Rick served in several senior leadership roles including CFO, Chief Accounting Officer, Controller, Treasurer, and Head of Investor Relations at four different companies over 20 years including Panera Bread Company, Heritage Home Group, and Merric Millwork and Seating, and Catholic Charities. He has a proven track record of leadership, strategic thinking, team development and execution, and business acumen which is welcomed at USAC during this period of change. Rick&#39;s broad range of experience in public accounting as well as in industry, which includes strategic planning, financial planning and analysis, operational finance, cash flow optimization, customer, supplier, and third-party management, and information technology, will complement and enhance the USAC senior leadership talent and skills.
Commenting on Rick Isaak&#39;s appointment today, Gary C. Evans, Lead Director, stated, &quot;Rick will be a key part of our new management team, the building process which is now in motion. His in-depth knowledge of cost accounting and SEC reporting requirements will greatly benefit USAC going forward. Rick also has a strong business sense and will be integral in our decision-making process of building, culling, and acquiring complementary businesses.&quot;

USAC Announces Appointment Richard R. Isaak Appointed As Senior Vice President & Chief Financial Officer

nited States Antimony Corporation (&quot;UAMY&quot;, &quot;U.S. Antimony&quot; or the &quot;Company&quot;) is pleased to announce that the Department of Defense (&quot;DOD&quot;) and the Defense Logistics Agency (&quot;DLA&quot;) have approved the third and final sample of antimony trisulfide supplied by the company. The samples were all taken from material obtained via concentrating feed from ore at the Sierra Guadalupe mines in the state of Zacatecas Mexico. The Company, in&nbsp;Q3&nbsp;of 2022, entered into a purchase agreement for the ownership of the mining concessions at the Sierra Guadalupe Mines and is currently engaged in negotiations for the surface rights. The mines were worked prior to 1970 and the approved material came from concentrate made from dump rock generated from that mining effort.
The Guadalupe supplied a small amount of high-grade feed for direct smelting in 2016-2018 that had an average grade of approximately&nbsp;32%&nbsp;antimony.
SUMMARY:
The mine, because of its predominance of sulfide ore, was acquired for the supply of ore to the Company&#39;s Puerto Blanco flotation facility for concentration followed by shipment to the Montana facilities for synthesis into purified antimony trisulfide crystal.
This approval means that U.S. Antimony now has the only approved North American mine source of antimony for the production and supply of antimony trisulfide to the DOD/DLA for primers in munitions.

U.S. Antimony Announces Approval Received From DOD For Third & Final Antimony Trisulfide Sample From The Sierra Guadalupe Mines

The Dow Jones closed higher by more than 250 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h2>Theriva Biologics </h2>
<ul>
<li>The Trade: Theriva Biologics, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tovx#NYSE">TOVX</a>) CEO and CFO Steven A Shallcross <a href="https://www.benzinga.com/sec/insider-trades/"> bought a total of 25,000 shares </a> at an average price of $0.75. To acquire these shares, it cost around $18.7 thousand.</li>
<li>What&rsquo;s Happening: Theriva Biologics received a notice of allowance for its U.S. patent application 16/982,211 titled &quot;Alkaline Phosphatase Agents For Treatment Of Radiation Disorders.&quot;</li>
<li>What Theriva Biologics Does: Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs.</li>
</ul>
<h2>United States Antimony </h2>
<ul>
<li>The Trade: United States Antimony Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uamy#NYSE">UAMY</a>) Director Lloyd Bardswich <a href="https://www.benzinga.com/quote/PSIX/analyst-ratings"> acquired a total of 10,000 shares </a> at an average price of $0.44. The insider spent around $4.4 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: On Nov. 21, 2022, United States Antimony&#39;s board approved a 5 million share stock buy back.</li>
<li>What United States Antimony Does: United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/23/01/30522315/5-most-expensive-consumer-stocks-you-should-worry-about"> 5 Most Expensive Consumer Stocks You Should Worry About</a>
<h2>Context Therapeutics</h2>
<ul>
<li>The Trade: Context Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cntx#NASDAQ">CNTX</a>) CEO Martin Lehr <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 6,839 shares </a> at an average price of $0.72. To acquire these shares, it cost around $4.9 thousand.</li>
<li>What&rsquo;s Happening: Context Therapeutics and Lonza recently announced that the companies are collaborating to manufacture CTIM-76, Context&#39;s clinical development candidate.</li>
<li>What Context Therapeutics Does: Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer.</li>
</ul>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here</a>
<h2>Precipio</h2>
<ul>
<li>The Trade: Precipio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prpo#NASDAQ">PRPO</a>) Director Sandberg Richard <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 20,000 shares </a> at an average price of $0.78. The insider spent $15.53 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: Precipio signed another major hemescreen customer for $650k per year.</li>
<li>What Precipio Does: Precipio Inc is a healthcare solutions company focused on cancer diagnostics.</li>
</ul>

Insider Trades

CNTX

PRPO

TOVX

Context Therapeutics And 3 Other Stocks Under $1 Insiders Are Aggressively Buying

SEC Form 4
<table border="0" cellpadding="4" cellspacing="0" style="width:100%">
<tbody>
<tr>
<td colspan="2">FORM 4</td>
<td rowspan="2">UNITED STATES SECURITIES AND EXCHANGE COMMISSION 
			Washington, D.C. 20549
			STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
			Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 
			or Section 30(h) of the Investment Company Act of 1940</td>
<td rowspan="2">
<table border="1" style="width:100%" summary="OMB Approval Status Box">
<tbody>
<tr>
<td>OMB APPROVAL</td>
</tr>
<tr>
<td>
<table border="0" style="width:100%" summary="OMB Interior Box">
<tbody>
<tr>
<td colspan="3">OMB Number:</td>
<td>3235-0287</td>
</tr>
<tr>
<td colspan="4">Estimated average burden</td>
</tr>
<tr>
<td colspan="3">hours per response:</td>
<td>0.5</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td>
<table border="1" cellpadding="0" cellspacing="0" style="width:100%">
<tbody>
<tr>
<td>&nbsp;&nbsp;</td>
</tr>
</tbody>
</table>
</td>
<td>Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.&nbsp;See&nbsp;Instruction 1(b).</td>
</tr>
</tbody>
</table>
<table border="1" cellpadding="4" cellspacing="0" style="width:100%">
<tbody>
<tr>
<td rowspan="3">1. Name and Address of Reporting Person&#x2A;
<table border="0" style="width:100%">
<tbody>
<tr>
<td><a href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001191410">EVANS GARY C</a></td>
</tr>
</tbody>
</table>
<hr />
<table border="0" style="width:100%">
<tbody>
<tr>
<td>(Last)</td>
<td>(First)</td>
<td>(Middle)</td>
</tr>
</tbody>
</table>
<table border="0" style="width:100%">
<tbody>
<tr>
<td>PO BOX 540308</td>
</tr>
<tr>
<td>&nbsp;</td>
</tr>
</tbody>
</table>
<hr />(Street)
<table border="0" style="width:100%">
<tbody>
<tr>
<td>DALLAS</td>
<td>TX</td>
<td>75354</td>
</tr>
</tbody>
</table>
<hr />
<table border="0" style="width:100%">
<tbody>
<tr>
<td>(City)</td>
<td>(State)</td>
<td>(Zip)</td>
</tr>
</tbody>
</table>
</td>
<td>2. Issuer Name&nbsp;and&nbsp;Ticker or Trading Symbol 
			<a href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0000101538">UNITED STATES ANTIMONY CORP</a>&nbsp;[&nbsp;UAMY&nbsp;]</td>
<td rowspan="2">5. Relationship of Reporting Person(s) to Issuer 
			(Check all applicable)
<table border="0" style="width:100%">
<tbody>
<tr>
<td>X</td>
<td>Director</td>
<td>&nbsp;</td>
<td>10%&nbsp;Owner</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>Officer (give title below)</td>
<td>&nbsp;</td>
<td>Other (specify below)</td>
</tr>
<tr>
<td colspan="4">&nbsp;</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td>3. Date of Earliest Transaction (Month/Day/Year) 
			12/07/2022</td>
</tr>
<tr>
<td>4. If Amendment, Date of Original Filed (Month/Day/Year)</td>
<td>6. Individual or Joint/Group Filing (Check Applicable Line)
<table border="0" style="width:100%">
<tbody>
<tr>
<td>X</td>
<td>Form filed by One Reporting Person</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>Form filed by More than One Reporting Person</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
<table border="1" cellpadding="4" cellspacing="0" style="width:100%">
<thead>
<tr>
<th colspan="11">Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned</th>
</tr>
<tr>
<th rowspan="2">1. Title of Security (Instr. 3)</th>
<th rowspan="2">2. Transaction Date (Month/Day/Year)</th>
<th rowspan="2">2A. Deemed Execution Date, if any (Month/Day/Year)</th>
<th colspan="2">3. Transaction Code (Instr. 8)</th>
<th colspan="3">4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)</th>
<th rowspan="2">5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)</th>
<th rowspan="2">6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)</th>
<th rowspan="2">7. Nature of Indirect Beneficial Ownership (Instr. 4)</th>
</tr>
<tr>
<th>Code</th>
<th>V</th>
<th>Amount</th>
<th>(A) or (D)</th>
<th>Price</th>
</tr>
</thead>
<tbody>
<tr>
<td>UAMY - Common Stock</td>
<td>12/07/2022</td>
<td>12/07/2022</td>
<td>P</td>
<td>&nbsp;</td>
<td>251,281</td>
<td>A</td>
<td>$0.4</td>
<td>291,281</td>
<td>D</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>UAMY - Common Stock</td>
<td>12/08/2022</td>
<td>12/08/2022</td>
<td>P</td>
<td>&nbsp;</td>
<td>51,653</td>
<td>A</td>
<td>$0.41</td>
<td>342,934</td>
<td>D</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>UAMY - Common Stock</td>
<td>12/09/2022</td>
<td>12/09/2022</td>
<td>P</td>
<td>&nbsp;</td>
<td>65,902</td>
<td>A</td>
<td>$0.42</td>
<td>408,836</td>
<td>D</td>
<td>&nbsp;</td>
</tr>
</tbody>
</table>
<table border="1" cellpadding="4" cellspacing="0" style="width:100%">
<thead>
<tr>
<th colspan="16">Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned 
			(e.g., puts, calls, warrants, options, convertible securities)</th>
</tr>
<tr>
<th rowspan="2">1. Title of Derivative Security (Instr. 3)</th>
<th rowspan="2">2. Conversion or Exercise Price of Derivative Security</th>
<th rowspan="2">3. Transaction Date (Month/Day/Year)</th>
<th rowspan="2">3A. Deemed Execution Date, if any (Month/Day/Year)</th>
<th colspan="2">4. Transaction Code (Instr. 8)</th>
<th colspan="2">5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)</th>
<th colspan="2">6. Date Exercisable and Expiration Date (Month/Day/Year)</th>
<th colspan="2">7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)</th>
<th rowspan="2">8. Price of Derivative Security (Instr. 5)</th>
<th rowspan="2">9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)</th>
<th rowspan="2">10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)</th>
<th rowspan="2">11. Nature of Indirect Beneficial Ownership (Instr. 4)</th>
</tr>
<tr>
<th>Code</th>
<th>V</th>
<th>(A)</th>
<th>(D)</th>
<th>Date Exercisable</th>
<th>Expiration Date</th>
<th>Title</th>
<th>Amount or Number of Shares</th>
</tr>
</thead>
</table>
<table border="0" style="width:100%">
<tbody>
<tr>
<td>Explanation of Responses:</td>
</tr>
</tbody>
</table>
<table border="0" style="width:100%">
<tbody>
<tr>
<td>&nbsp;</td>
<td>/s/ Gary C. Evans</td>
<td>12/12/2022</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>&#x2A;&#x2A; Signature of Reporting Person</td>
<td>Date</td>
</tr>
<tr>
<td colspan="3">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td>
</tr>
<tr>
<td colspan="3">&#x2A; If the form is filed by more than one reporting person,&nbsp;see&nbsp;Instruction 4 (b)(v).</td>
</tr>
<tr>
<td colspan="3">&#x2A;&#x2A; Intentional misstatements or omissions of facts constitute Federal Criminal Violations&nbsp;See&nbsp;18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td>
</tr>
<tr>
<td colspan="3">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,&nbsp;see&nbsp;Instruction 6 for procedure.</td>
</tr>
<tr>
<td colspan="3">Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</td>
</tr>
</tbody>
</table>

United States Antimony Corp. Form 4 Filing Shows Director Gary C. Evans Buys 368,836 Shares At An Average Price Of $0.40

Buybacks

On November 21, 2022 United States Antimony's Board Of Directors Approved A 5M Share Stock Buy Back

Options

SONN

SOUN

STOK

STRC

STTK

TCDA

TSLA

TTCF

TVTX

TYDE

UPWK

VCSA

VINC

VLTA

VRAX

VYNT

WISA

WKSP

WORX

WTER

XPON

Stocks That Hit 52-Week Lows On Tuesday

THCH

TNYA

TRKA

TRMB

TRUE

TSAT

TTEC

TUEM

TWKS

UAVS

UPLD

VBLT

VEDU

VEEE

VIOT

VIRI

VJET

VNTR

VRNS

VSTM

VVPR

VXRT

WILC

WIMI

WOOF

WPRT

XXII

YOSH

ZEPP

ZEST

ZIMV

ZKIN

Stocks That Hit 52-Week Lows On Monday

<h3>Gainers</h3>
<ul>
<li>Rail Vision Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvsn#NASDAQ">RVSN</a>) shares rose 38.5% to $1.87 in pre-market trading after gaining around 5% on Tuesday.</li>
<li>Brickell Biotech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbi#NASDAQ">BBI</a>) rose 29% to $0.2999 in pre-market trading after the company announced the sale of sofpironium bromide to Botanix Pharmaceuticals for $9 million in upfront and potential near-term regulatory milestone payments. The company is also eligible to receive additional success-based regulatory and sales milestone payments of up to $168 million.</li>
<li>Aclarion, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acon#NASDAQ">ACON</a>) rose 28.5% to $2.21 in pre-market trading after declining over 5% on Tuesday. The company had its IPO on April 22.</li>
<li>Livent Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lthm#NYSE">LTHM</a>) rose 23.1% to $26.98 in pre-market trading after the company reported better-than-expected Q1 results and raised FY22 guidance.</li>
<li>Sharps Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stss#NASDAQ">STSS</a>) rose 20.3% to $1.54 in pre-market trading after climbing around 6% on Tuesday.</li>
<li>United States Antimony Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uamy#NASDAQ">UAMY</a>) rose 16.5% to $0.48 in pre-market trading.</li>
<li>CASI Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/casi#NASDAQ">CASI</a>) rose 15% to $0.49 in pre-market trading.</li>
<li>Senmiao Technology Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aihs#NASDAQ">AIHS</a>) rose 12.3% to $1.27 in pre-market trading.</li>
<li>Amesite Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amst#NASDAQ">AMST</a>) shares rose 10.7% to $0.7096 in pre-market trading after declining over 6% on Tuesday.</li>
<li>Alaunos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcrt#NASDAQ">TCRT</a>) rose 9.9% to $0.61 in pre-market trading after jumping around 13% on Tuesday.</li>
<li>Expion360 Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xpon#NASDAQ">XPON</a>) rose 9.7% to $3.96 in pre-market trading. Expion360 secured $300,000 line of credit from GM Financial to support expansion of national sales and distribution channels.</li>
<li>CNS Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnsp#NASDAQ">CNSP</a>) rose 8.6% to $0.38 in pre-market trading.</li>
<li>The Scotts Miracle-Gro Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smg#NYSE">SMG</a>) rose 7.6% to $114.00 in pre-market trading. Scotts Miracle-Gro announced record second-quarter sales in its U.S. consumer segment driven by continued support from its major retail partners.</li>
<li>Starbucks Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbux#NASDAQ">SBUX</a>) rose 6.4% to $79.10 in pre-market trading as the company reported second-quarter revenue of $7.64 billion, which was up 15% year-over-year. The quarterly revenue was a second-quarter record for the company and came in ahead of a consensus estimate of $7.6 billion.</li>
<li>Advanced Micro Devices, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amd#NASDAQ">AMD</a>) shares rose 6% to $96.60 in pre-market trading after the company reported better-than-expected Q1 adjusted EPS and sales results and raised FY22 sales guidance.</li>
</ul>

Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>.
<h3>Losers</h3>
<ul>
<li>Lyft, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyft#NASDAQ">LYFT</a>) shares fell 27.2% to $22.40 in pre-market trading. Lyft reported a narrower loss for its first quarter, while sales topped estimates. However, the company issued a weak outlook for the second quarter.</li>
<li>Herbalife Nutrition Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hlf#NYSE">HLF</a>) shares fell 15.6% to $23.25 in pre-market trading after the company reported a decline in Q1 EPS results.</li>
<li>Akamai Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akam#NASDAQ">AKAM</a>) fell 13.9% to $98.02 in pre-market trading after the company reported worse-than-expected Q1 results.</li>
<li>Blue Water Vaccines, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bwv#NASDAQ">BWV</a>) fell 13.5% to $5.58 in pre-market trading. Blue Water Vaccines S-1 showed registration for 2.4 million share common stock offering via selling shareholders.</li>
<li>IonQ, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ionq#NYSE">IONQ</a>) shares fell 13.5% to $6.18 in pre-market trading. IonQ shares dropped 9% on Tuesday following a short report by Scorpion Capital.</li>
<li>XORTX Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xrtx#NASDAQ">XRTX</a>) fell 10.9% to $1.63 in pre-market trading. XORTX Therapeutics shares jumped 59% on Tuesday after the company announced that dosing of human subjects has been initiated in the XRX-OXY-101 bridging pharmacokinetics study.</li>
<li>Revolve Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rvlv#NYSE">RVLV</a>) fell 9.9% to $39.20 in pre-market trading after the company reported Q1 earnings results.</li>
<li>Swvl Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swvl#NASDAQ">SWVL</a>) fell 8.5% to $6.62 in pre-market trading after dipping 17% on Tuesday.</li>
<li>Sonoma Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snoa#NASDAQ">SNOA</a>) shares fell 8.3% to $3.21 in pre-market trading. Sonoma Pharmaceuticals shares jumped around 32% on Tuesday after the company and its partner MicroSafe Group DMCC received EPA approval for Nanocyn as a hospital-grade disinfectant.</li>
<li>Redbox Entertainment Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdbx#NASDAQ">RDBX</a>) fell 7.6% to $6.12 in pre-market trading after dipping 22% on Tuesday.</li>
<li>Ouster, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/oust#NYSE">OUST</a>) fell 6.3% to $3.25 in pre-market trading after the company reported worse-than-expected Q1 results.</li>
<li>Match Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtch#NASDAQ">MTCH</a>) fell 6.3% to $74.05 in pre-market trading after the company reported Q1 earnings results and issued Q2 sales guidance below analyst estimates.</li>
</ul>

Movers

ACON

AIHS

AKAM

AMST

CASI

CNSP

IONQ

LTHM

LYFT

MTCH

OUST

RDBX

RVLV

RVSN

SBUX

SNOA

STSS

SWVL

TCRT

XRTX

27 Stocks Moving in Wednesday's Pre-Market Session

United States Antimony Corporation (USAC-the Company) is pleased to provide this operational update. The improvements in production and efficiency continues at all locations. A detailed geophysical program at Los Juarez has been initiated and the head geologist is at Los Juarez.
Operations Updated- January and February
Safety and Environmental
All Company operations reported&nbsp;zero lost time&nbsp;or serious injury accidents during the January-February Period.
There were&nbsp;zero&nbsp;environmental spills, discharges, or incidents during the period. The previously announced (see NR- Jan. 15, 2022) pro-active program of legacy slag clean-up at the Madero Smelter continued and is now&nbsp;86%&nbsp;complete. Concurrently, the Company is aggressively reducing its stockpile of legacy slags in Montana. In January, 80,000 lbs were shipped and in February 120,000 lbs were shipped. The Company has 178,000 lbs of this legacy slag left to ship.
Production&nbsp;(Unless otherwise specified, tons = metric tons)
<table>
<tbody>
<tr>
<td rowspan="1">
Bear River Zeolite (&quot;BRZ&quot;)
</td>
<td colspan="2">January</td>
<td colspan="2">February</td>
<td colspan="2">Total</td>
</tr>
<tr>
<td>
Mined Tons:
</td>
<td colspan="1">0</td>
<td colspan="1">0</td>
<td colspan="1">0 (mine closed winter months)</td>
</tr>
<tr>
<td>
Crushed Tons:
</td>
<td colspan="1">628</td>
<td colspan="1">474</td>
<td colspan="1">1,102</td>
</tr>
<tr>
<td>
Sold Tons:
</td>
<td colspan="1">791</td>
<td colspan="1">1,613</td>
<td colspan="1">2,404</td>
</tr>
</tbody>
</table>
The total sold tonnage is&nbsp;46.6%&nbsp;increase over the 1,640 tons shipped in Jan-Feb 2021.
<table>
<tbody>
<tr>
<td rowspan="1">
Mexican Smelter:
</td>
<td colspan="2">January</td>
<td colspan="2">February</td>
<td colspan="2">Total</td>
</tr>
<tr>
<td>
Purified antimony metal sold (tons):
</td>
<td colspan="1">20</td>
<td colspan="1">20</td>
<td colspan="1">40</td>
</tr>
</tbody>
</table>
<table>
<tbody>
<tr>
<td rowspan="1">
Montana Smelter:
</td>
<td colspan="2">January</td>
<td colspan="2">February</td>
<td colspan="2">Total</td>
</tr>
<tr>
<td>
Antimony Trioxide sold (tons):
</td>
<td colspan="1">40.1</td>
<td colspan="1">55.7</td>
<td colspan="1">95.8</td>
</tr>
</tbody>
</table>
(NOTE: Tons of antimony trioxide sold were&nbsp;130%&nbsp;higher&nbsp;and average sale price&nbsp;91.6%&nbsp;higher&nbsp;in 2022 than for same period in 2021!)
<table>
<tbody>
<tr>
<td>
Antimony Trisulfide produced (lbs):
</td>
<td colspan="1">1,986</td>
<td colspan="1">1,105</td>
<td colspan="1">3,091</td>
</tr>
</tbody>
</table>

US Antimony Reports Zero Lost Time Or Serious Injury Accidents During January-February Period

<h3>Gainers</h3>
<ul>
<li>Hycroft Mining Holding Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hymc#NASDAQ">HYMC</a>) shares jumped 138.1% to close at $1.50 on Thursday after dropping 37% on Wednesday.</li>
<li>AgriFORCE Growing Systems, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agri#NASDAQ">AGRI</a>) gained 102.4% to close at $3.42 after the company announced a binding letter of intent to acquire Deroose Planta NV.</li>
<li>Enservco Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ensv#NYSE">ENSV</a>) shares jumped 43.1% to close at $4.32 after dropping 28% on Wednesday.</li>
<li>Hoth Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hoth#NASDAQ">HOTH</a>) gained 38.8% to close at $0.7968 following circulation of an FDA AccessData.gov listing which showed the company&#39;s c-KIT-targeting candidate received orphan-drug designation.</li>
<li>AquaBounty Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aqb#NASDAQ">AQB</a>) surged 37.8% to close at $1.93 after the company reported FY21 EPS results were higher year over year.</li>
<li>Salarius Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slrx#NASDAQ">SLRX</a>) jumped 33.4% to close at $0.50.</li>
<li>Almaden Minerals Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aau#NYSE">AAU</a>) gained 32.9% to settle at $0.4480.</li>
<li>Ebix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ebix#NASDAQ">EBIX</a>) jumped 31.4% to settle at $41.90 on Thursday. The company recently posted upbeat quarterly sales.</li>
<li>Arcadia Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rkda#NASDAQ">RKDA</a>) surged 31.3% to close at $1.53 following circulation of a WIPO PatentScope document for Arcadia&#39;s &#39;METHODS OF INCREASING FIBER IN A WHEAT GRAIN.&#39;</li>
<li>Tiziana Life Sciences PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tlsa#NASDAQ">TLSA</a>) jumped 30.4% to settle at $0.9557 after the company announced clinical data from a secondary progressive multiple sclerosis patient treated for six months with intranasally administered foralumab.</li>
<li>Impac Mortgage Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/imh#NYSE">IMH</a>) rose 29.1% to close at $0.90. The company posted a Q4 profit after the closing bell on Thursday.</li>
<li>Sonic Foundry, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sofo#NASDAQ">SOFO</a>) gained 26.7% to close at $3.8036.</li>
<li>The Very Good Food Company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vgfc#NASDAQ">VGFC</a>) surged 26.3% to close at $0.6818.</li>
<li>Eco Wave Power Global AB (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wave#NASDAQ">WAVE</a>) gained 25.2% to close at $6.26 following a 15% decline on Wednesday.</li>
<li>GreenLight Biosciences Holdings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grna#NASDAQ">GRNA</a>) rose 24.4% to close at $9.84.</li>
<li>iPower Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ipw#NASDAQ">IPW</a>) gained 24.3% to close at $1.79.</li>
<li>RiceBran Technologies (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ribt#NASDAQ">RIBT</a>) gained 24.1% to settle at $0.49.</li>
<li>Snow Lake Resources Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/litm#NASDAQ">LITM</a>) rose 24.1% to close at $7.53. Snow Lake Lithium issued an update on progress of its winter drilling program.</li>
<li>Pop Culture Group Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cpop#NASDAQ">CPOP</a>) surged 23.6% to settle at $1.57.</li>
<li>Barfresh Food Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brfh#NASDAQ">BRFH</a>) gained 23.2% to close at $6.65. Barfresh Food Group posted Q4 adjusted EBITDA loss of $66.65K.</li>
<li>Pintec Technology Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pt#NASDAQ">PT</a>) gained 21.5% to settle at $0.5801 after jumping around 14% on Wednesday.</li>
<li>Calyxt, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clxt#NASDAQ">CLXT</a>) surged 20.2% to close at $1.55.</li>
<li>SenesTech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snes#NASDAQ">SNES</a>) gained 19.1% to close at $0.9398.</li>
<li>Indonesia Energy Corporation Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/indo#NYSE">INDO</a>) jumped 18.7% to close at $39.93. The company announced that it commenced drilling of two back-to-back production wells at the Kruh block.</li>
<li>Red Violet, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdvt#NASDAQ">RDVT</a>) gained 18.5% to close at $27.82 after the company reported Q4 sales results were higher year over year.</li>
<li>TRACON Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcon#NASDAQ">TCON</a>) gained 18.2% to close at $2.92. TRACON Pharma reported FDA approval of amended ENVASARC protocol.</li>
<li>TMC the metals company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmc#NASDAQ">TMC</a>) gained 17.2% to close at $2.39.</li>
<li>Yield10 Bioscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yten#NASDAQ">YTEN</a>) shares rose 16.6% to close at $5.40 following better-than-expected Q4 results.</li>
<li>Grom Social Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grom#NASDAQ">GROM</a>) gained 15.8% to close at $1.05.</li>
<li>Natera, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntra#NASDAQ">NTRA</a>) jumped 15.8% to close at $42.61. Shares closed down more than 30% Wednesday. The company responded and said it disagreed with the accuracy of the report. Analysts at Canaccord and Piper defended the stock.</li>
<li>CVR Energy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cvi#NYSE">CVI</a>) gained 15.7% to close at $23.37.</li>
<li>United States Antimony Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uamy#NYSE">UAMY</a>) surged 14.9% to close at $0.6982.</li>
<li>Quoin Pharmaceuticals, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qnrx#NASDAQ">QNRX</a>) gained 14.3% to close at $1.3835.</li>
<li>Checkpoint Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ckpt#NASDAQ">CKPT</a>) surged 13.8% to close at $1.90.</li>
<li>LSB Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lxu#NYSE">LXU</a>) rose 12.9% to settle at $20.99.</li>
<li>Clarivate Plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/clvt#NYSE">CLVT</a>) surged 12.8% to close at $14.65 after the company reported better-than-expected Q4 adjusted EPS and sales results.</li>
<li>CrowdStrike Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crwd#NASDAQ">CRWD</a>) rose 12.5% to close at $191.02 after the company reported better-than-expected Q4 results. The company also issued both Q1 and FY23 adjusted EPS and sales guidance above analyst estimates.</li>
<li>Genesco Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gco#NYSE">GCO</a>) shares rose 11.8% to close at $70.49 after the company reported better-than-expected Q4 adjusted EPS and sales results and issued FY23 guidance.</li>
<li>Cvent Holding Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cvt#NASDAQ">CVT</a>) gained 11.7% to close at $8.91.</li>
<li>China Green Agriculture, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cga#NYSE">CGA</a>) gained 13.1% to close at $10.70.</li>
<li>Cerberus Cyber Sentinel Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciso#NASDAQ">CISO</a>) gained 7.5% to close at $5.29.</li>
<li>CEA Industries Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cead#NASDAQ">CEAD</a>) shares gained 7.3% to close at $2.20 on Thursday after the company reported it signed a $2.1 million contract.</li>
</ul>
&nbsp;
<h3>Losers</h3>
<ul>
<li>Trean Insurance Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tig#NASDAQ">TIG</a>) shares tumbled 51.7% to close at $3.40 on Thursday after the company reported Q4 earnings results and provided guidance.</li>
<li>Myomo, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/myo#NYSE">MYO</a>) fell 41.4% to close at $4.34 after the company reported worse-than-expected Q4 EPS results.</li>
<li>Yatsen Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ysg#NYSE">YSG</a>) dropped 39.5% to close at $0.7502 after the company reported Q4 earnings results.</li>
<li>Fossil Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fosl#NASDAQ">FOSL</a>) fell 37.5% to close at $9.08 after the company reported Q4 earnings results.</li>
<li>TherapeuticsMD, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/txmd#NASDAQ">TXMD</a>) dipped 27.5% to close at $0.29 after the company reported worse-than-expected Q4 EPS and sales results.</li>
<li>KE Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/beke#NYSE">BEKE</a>) declined 23.9% to close at $11.00 after the company reported Q4 earnings results.</li>
<li>Sentage Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sntg#NASDAQ">SNTG</a>) dropped 22.2% to settle at $1.26.</li>
<li>ACM Research, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acmr#NASDAQ">ACMR</a>) fell 22.1% to close at $63.80. ACM Research recently reported a 3-for-1 stock split.</li>
<li>Asana, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/asan#NYSE">ASAN</a>) shares fell 22.1% to close at $38.01 after the company reported Q4 earnings results and issued Q1 adjusted EPS guidance below analyst estimates. JP Morgan downgraded Asana from Neutral to Underweight and lowered the price target from $66 to $32.</li>
<li>iQIYI, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iq#NASDAQ">IQ</a>) dipped 21.7% to close at $3.21. Shares of Chinese companies traded lower amid multiple possible catalysts including overall market weakness following the collapse of Russia-Ukraine ceasefire talks as well as weakness in JD.com following Q4 earnings.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcbp#NASDAQ">TCBP</a>) shares fell 21.7% to close at $1.08 after climbing around 42% on Wednesday.</li>
<li>Sunshine Biopharma, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbfm#NASDAQ">SBFM</a>) shares dipped 21.6% to close at $2.98 after the company announced pricing of an $8 million private placement at-the-market.</li>
<li>SuRo Capital Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssss#NASDAQ">SSSS</a>) fell 21.3% to close at $8.92. SuRo Capital reported FY21 net asset value of $11.72. BTIG maintained SuRo Capital with a Buy and lowered the price target from $20 to $16.</li>
<li>Jianpu Technology Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jt#NYSE">JT</a>) fell 19.5% to close at $1.20.</li>
<li>Intellicheck, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/idn#NYSE">IDN</a>) dipped 19% to close at $2.56 following Q4 results.</li>
<li>VNET Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vnet#NASDAQ">VNET</a>) fell 18.7% to close at $5.51.</li>
<li>OneSmart International Education Group Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/one#NYSE">ONE</a>) fell 18.6% to close at $1.93. Shares of Chinese companies traded lower amid multiple possible catalysts including overall market weakness following the collapse of Russia-Ukraine ceasefire talks as well as weakness in JD.com following Q4 earnings.</li>
<li>Build-A-Bear Workshop, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bbw#NYSE">BBW</a>) dropped 18.3% to close at $16.04 after the company reported Q4 earnings results.</li>
<li>NexImmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nexi#NASDAQ">NEXI</a>) fell 17.8% to close at $1.89. NexImmune filed for mixed shelf of up to $200 million.</li>
<li>Revelation Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/revb#NASDAQ">REVB</a>) fell 17.7% to close at $1.40 after gaining around 84% on Wednesday.</li>
<li>Pinduoduo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pdd#NASDAQ">PDD</a>) fell 17.5% to close at $35.76.</li>
<li>JinkoSolar Holding Co., Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jks#NYSE">JKS</a>) dipped 17.5% to close at $47.04.</li>
<li>The Vita Coco Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coco#NASDAQ">COCO</a>) dropped 17.5% to close at $8.65 following Q4 results.</li>
<li>Acorda Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acor#NASDAQ">ACOR</a>) fell 17.3% to close at $1.87. Acorda Therapeutics posted a Q4 loss of $0.67 per share.</li>
<li>Alaunos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcrt#NASDAQ">TCRT</a>) fell 17.2% to close at $0.7348.</li>
<li>The Dixie Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dxyn#NASDAQ">DXYN</a>) dropped 17.1% to $3.10 as the company posted a wider quarterly loss.</li>
<li>TAL Education Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tal#NYSE">TAL</a>) fell 16.7% to close at $2.44.</li>
<li>Coupang, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cpng#NYSE">CPNG</a>) fell 16.6% to close at $18.94.</li>
<li>JD.com, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jd#NASDAQ">JD</a>) dipped 15.8% to close at $52.52 after the company reported Q4 earnings results.</li>
<li>Baozun Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bzun#NASDAQ">BZUN</a>) fell 15.8% to close at $7.59. Baozun reported a fourth-quarter FY21 revenue decline of 5.2% year-on-year to $497.9 million.</li>
<li>Bilibili Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bili#NASDAQ">BILI</a>) dipped 14.1% to close at $21.68.</li>
<li>Lightbridge Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ltbr#NASDAQ">LTBR</a>) shares fell 13.9% to settle at $10.75 after climbing 30% on Wednesday.</li>
<li>NIO Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nio#NYSE">NIO</a>) fell 11.9% to close at $17.77.</li>
<li>Couchbase, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/base#NASDAQ">BASE</a>) dipped 9.6% to close at $10.75 after the company reported Q4 earnings results.</li>
<li>Agora, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/api#NASDAQ">API</a>) fell 9.4% to settle at $10.08 after climbing 14% on Wednesday.</li>
<li>MoneyLion Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ml#NYSE">ML</a>) fell 6.5% to close at $2.30. MoneyLion posted a Q4 adjusted net loss of $33.999 million.</li>
</ul>

ACMR

ACOR

AGRI

ASAN

BASE

BEKE

BILI

BRFH

BZUN

CEA INDUSTRIES INC by CEA Industries Inc.

CEAD

CISO

CKPT

CLVT

CLXT

COCO

CPNG

CPOP

CRWD

DXYN

EBIX

ENSV

FOSL

GRNA

GROM

HOTH

Hycroft Mining Holding Corporation - Class A Common Stock

HYMC

INDO

LITM

LTBR

NEXI

NTRA

Citigourp Global Markets 2% Protected Notes Linked To The Djia

QNRX

RDVT

REVB

RIBT

RKDA

SBFM

SLRX

SNES

SNTG

SOFO

SSSS

TCBP

TCON

TLSA

TXMD

VGFC

VNET

WAVE

YTEN

78 Biggest Movers From Yesterday

<h3>Gainers</h3>
<ul>
<li>Hycroft Mining Holding Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hymc#NASDAQ">HYMC</a>) climbed 203.3% to settle at $1.00 on Tuesday. Hycroft recently reported preliminary FY21 operating results.</li>
<li>Kala Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kala#NASDAQ">KALA</a>) gained 88.5% to close at $1.15 after the company announced UnitedHealthcare has added EYSUVIS as a covered brand on its commercial formularies and Cigna Medicare has added EYSUVIS as a preferred brand.</li>
<li>Enservco Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ensv#NYSE">ENSV</a>) jumped 68% to close at $4.20 on Tuesday after jumping around 85% on Monday.</li>
<li>Nine Energy Service, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nine#NYSE">NINE</a>) gained 57.7% to close at $5.66 after the company reported upbeat Q4 results. The company&rsquo;s stock jumped over 99% on Monday.</li>
<li>Westport Fuel Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wprt#NASDAQ">WPRT</a>) rose 52.6% to settle at $2.03 amid continued market volatility stemming from the Russia-Ukraine war.</li>
<li>Eco Wave Power Global AB (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wave#NASDAQ">WAVE</a>) jumped 50.9% to close at $5.90.</li>
<li>Energy Focus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/efoi#NASDAQ">EFOI</a>) jumped 46.7% to close at $1.79.</li>
<li>Cyren Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyrn#NASDAQ">CYRN</a>) gained 45.6% to close at $10.41 amid strength in cybersecurity names as the Russia-Ukraine conflict has raised cyberattack concerns.</li>
<li>Independence Contract Drilling, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/icd#NYSE">ICD</a>) surged 40.6% to close at $7.07. Independence Contract posted a Q4 loss of $1.35 per share.</li>
<li>PolyMet Mining Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/plm#NYSE">PLM</a>) shares climbed 39.5% to close at $3.99 after jumping around 9% on Monday.</li>
<li>ReneSola Ltd (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sol#NYSE">SOL</a>) jumped 36.5% to settle at $8.11 on continued momentum as a surge in oil prices lifted alternative energy names.</li>
<li>Great Panther Mining Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gpl#NYSE">GPL</a>) surged 34.6% to settle at $0.3595.</li>
<li>SilverSun Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssnt#NASDAQ">SSNT</a>) gained 34.2% to close at $4.32.</li>
<li>TMC the metals company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmc#NASDAQ">TMC</a>) jumped 33.3% to close at $2.20 after climbing 18% on Monday.</li>
<li>Voyager Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vygr#NASDAQ">VYGR</a>) rose 33.3% to close at $1.60. Voyager Therapeutics reported license option agreement with Novartis for target-specific access to next-generation TRACER&trade; AAV capsids for gene therapy programs.</li>
<li>Team, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tisi#NYSE">TISI</a>) gained 32.1% to close at $1.17.</li>
<li>BIO-key International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bkyi#NASDAQ">BKYI</a>) rose 31.8% to close at $2.82.</li>
<li>Wejo Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wejo#NASDAQ">WEJO</a>) gained 30.3% to close at $3.74.</li>
<li>Asia Pacific Wire &amp; Cable Corporation Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apwc#NASDAQ">APWC</a>) surged 29.3% to close at $2.03.</li>
<li>Inpixon (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inpx#NASDAQ">INPX</a>) gained 28.8% to settle at $0.38.</li>
<li>Gevo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gevo#NASDAQ">GEVO</a>) climbed 28.7% to close at $4.53.</li>
<li>Marine Petroleum Trust (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/marps#NASDAQ">MARPS</a>) rose 27.9% to close at $15.49 after jumping around 70% on Monday.</li>
<li>Safe-T Group Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfet#NASDAQ">SFET</a>) gained 27.7% to close at $1.08.</li>
<li>Sentage Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sntg#NASDAQ">SNTG</a>) surged 27.7% to settle at $1.10.</li>
<li>Guardforce AI Co., Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gfai#NASDAQ">GFAI</a>) gained 25.9% to close at $0.5901.</li>
<li>Save Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/svfd#NASDAQ">SVFD</a>) jumped 25.1% to settle at $6.63.</li>
<li>Lilium N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lilm#NASDAQ">LILM</a>) surged 25% to close at $3.95.</li>
<li>Vertex Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtnr#NASDAQ">VTNR</a>) gained 24.2% to settle at $7.66. Vertex Energy posted a Q4 loss of $0.36 per share.</li>
<li>Ocean Power Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/optt#NYSE">OPTT</a>) surged 24.1% to close at $1.65.</li>
<li>EZGO Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ezgo#NASDAQ">EZGO</a>) gained 24% to settle at $1.0350.</li>
<li>Maxeon Solar Technologies, Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/maxn#NYSE">MAXN</a>) surged 23.6% to close at $13.62 on continued momentum as a surge in oil prices lifts alternative energy names.</li>
<li>UroGen Pharma Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/urgn#NASDAQ">URGN</a>) gained 23.3% to settle at $7.67. UroGen secured $100 million non-dilutive term loan financing with Pharmakon Advisors.</li>
<li>Fusion Fuel Green PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htoo#NASDAQ">HTOO</a>) climbed 22.2% to settle at $7.81 amid continued market volatility stemming from the Russia-Ukraine war. US President Biden later confirmed a ban on Russian oil imports.</li>
<li>CynergisTek, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctek#NYSE">CTEK</a>) gained 21.3% to close at $1.65 amid strength in cybersecurity names as cyberattack concerns mount.</li>
<li>Aemetis, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amtx#NASDAQ">AMTX</a>) jumped 20.7% to close at $15.02 amid continued strength in oil and natural gas prices. The Russia-Ukraine conflict has caused supply concerns while prospects of a US ban on Russian oil imports has further lifted prices.</li>
<li>Sunworks, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sunw#NYSE">SUNW</a>) climbed 20.5% to settle at $3.77 amid continued market volatility stemming from the Russia-Ukraine war. US President Biden confirmed a ban on Russian oil imports.</li>
<li>Xos, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xos#NASDAQ">XOS</a>) gained 19.1% to close at $2.56.</li>
<li>Research Frontiers Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/refr#NASDAQ">REFR</a>) surged 19% to settle at $2.38.</li>
<li>United States Antimony Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uamy#NYSE">UAMY</a>) rose 18.8% to close at $0.6297 after jumping more than 12% on Monday.</li>
<li>PBF Energy Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pbf#NYSE">PBF</a>) jumped 18.7% to close at $23.54 after B of A Securities upgraded the stock from Neutral to Buy.</li>
<li>SunPower Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spwr#NASDAQ">SPWR</a>) gained 18.7% to close at $20.66 as a surge in oil prices lifted alternative energy names.</li>
<li>Viemed Healthcare, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vmd#NASDAQ">VMD</a>) jumped 18.2% to close at $4.23 after the company reported Q4 results and announced up to 1,984,014 share buyback program.</li>
<li>Spartan Acquisition Corp. III (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spaq#NYSE">SPAQ</a>) gained 17.6% to close at $11.61. Spartan Acquisition Corp. III shareholders approved SPAC merger deal with Allego Holding.</li>
<li>Ecoark Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zest#NASDAQ">ZEST</a>) climbed 17.3% to settle at $3.05.</li>
<li>U.S. Energy Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/useg#NASDAQ">USEG</a>) rose 16.5% to close at $7.36.</li>
<li>XL Fleet Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xl#NYSE">XL</a>) gained 16.2% to settle at $2.29.</li>
<li>Superior Drilling Products, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sdpi#NYSE">SDPI</a>) climbed 15.9% to close at $1.60 after gaining around 14% on Monday. Superior Drilling Products is expected to release its Q4 financial results on Friday, March 11, 2022.</li>
<li>Fuel Tech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ftek#NASDAQ">FTEK</a>) rose 15.5% to close at $1.42. The company is scheduled to release earnings after the closing bell on Tuesday.</li>
<li>CPS Technologies Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cpsh#NASDAQ">CPSH</a>) gained 15.1% to close at $3.0150.</li>
<li>Broadwind, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bwen#NASDAQ">BWEN</a>) gained 14.9% to settle at $2.32 amid continued market volatility stemming from the Russia-Ukraine war.</li>
<li>Beam Global (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/beem#NASDAQ">BEEM</a>) gained 13.7% to close at $16.66 amid continued market volatility stemming from the Russia-Ukraine war.</li>
<li>Ballard Power Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bldp#NASDAQ">BLDP</a>) jumped 13.6% to close at $11.56 amid continued market volatility stemming from the Russia-Ukraine war.</li>
<li>IsoPlexis Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iso#NASDAQ">ISO</a>) climbed 11.6% to close at $4.63. IsoPlexis recently reported Q4 earnings results and issued FY22 sales guidance below estimates.</li>
<li>Solitario Zinc Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xpl#NYSE">XPL</a>) shares rose 11.5% to settle at $0.8030 after dropping 8% on Monday.</li>
<li>Nabors Industries Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nbr#NYSE">NBR</a>) gained 11.2% to close at $159.33 amid continued strength in oil and natural gas prices.</li>
<li>SPI Energy Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spi#NASDAQ">SPI</a>) rose 11.2% to settle at $3.86 after climbing 28% on Monday.</li>
<li>Polar Power, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pola#NASDAQ">POLA</a>) rose 10.7% to close at $4.55 on continued momentum as a surge in oil prices lifts alternative energy names.</li>
<li>Profire Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pfie#NASDAQ">PFIE</a>) rose 9% to close at $1.46. Profire Energy is expected to report quarterly earnings on Wednesday, March 9, 2022.</li>
<li>Kosmos Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kos#NYSE">KOS</a>) surged 8.2% to close at $6.08 amid continued strength in oil and natural gas prices.</li>
<li>Evolve Transition Infrastructure LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snmp#NYSE">SNMP</a>) rose 7.9% to close at $0.96 after jumping 31% on Monday.</li>
<li>Dave Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dave#NASDAQ">DAVE</a>) rose 6.9% to close at $4.36.</li>
</ul>
&nbsp;
<h3>Losers</h3>
<ul>
<li>Indonesia Energy Corporation Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/indo#NYSE">INDO</a>) shares tumbled 49.6% to close at $31.00 after climbing more than 50% on Monday.</li>
<li>Imperial Petroleum Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/impp#NASDAQ">IMPP</a>) shares dipped 43.3% to close at $4.25 on Tuesday.</li>
<li>Inspirato Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ispo#NASDAQ">ISPO</a>) shares fell 42.8% to close at $15.25 after dipping 37% on Monday.</li>
<li>Houston American Energy Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/husa#NYSE">HUSA</a>) fell 38.5% to close at $6.95.</li>
<li>Digital Brands Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dbgi#NASDAQ">DBGI</a>) dropped 30.6% to settle at $1.36. Dbgi announced a 766% increase in e-commerce revenues for January and February.</li>
<li>New Concept Energy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gbr#NYSE">GBR</a>) fell 28.5% to settle at $3.77.</li>
<li>Pyxis Tankers Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pxs#NASDAQ">PXS</a>) fell 23.4% to close at $0.7656.</li>
<li>Yield10 Bioscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yten#NASDAQ">YTEN</a>) fell 21.3% to settle at $4.33. Yield10 Bioscience announced recent advances in the development of camelina as a production platform for PHA Bioplastic.</li>
<li>CKX Lands, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ckx#NYSE">CKX</a>) dropped 20.2% to close at $11.03.</li>
<li>Laird Superfood, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lsf#NYSE">LSF</a>) declined 19.9% to settle at $3.99. Laird Superfood posted a Q4 loss of $0.76 per share.</li>
<li>GBS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbs#NASDAQ">GBS</a>) fell 19.7% to close at $0.67.</li>
<li>Altamira Therapeutics Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyto#NASDAQ">CYTO</a>) fell 19.3% to settle at $0.7145. Altamira Therapeutics recently entered into an exclusive licensing and distribution agreement with Nuance Pharma Ltd in the Chinese Mainland, Hong Kong, Macau, and South Korea for Bentrio.</li>
<li>Barnwell Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/brn#NYSE">BRN</a>) dropped 19.1% to close at $3.95.</li>
<li>AutoWeb, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/auto#NASDAQ">AUTO</a>) fell 19% to close at $1.75.</li>
<li>Barnes &amp; Noble Education, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bned#NYSE">BNED</a>) fell 18.8% to settle at $3.89 after the company reported worse-than-expected Q3 sales results.</li>
<li>BigBear.ai Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bbai#NYSE">BBAI</a>) fell 17.5% to close at $7.93.</li>
<li>Top Ships Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tops#NASDAQ">TOPS</a>) dipped 16.8% to close at $1.24.</li>
<li>ION Geophysical Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/io#NYSE">IO</a>) dipped 16.6% to close at $1.16.</li>
<li>TROOPS, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/troo#NASDAQ">TROO</a>) fell 14.7% to settle at $2.50.</li>
<li>Mexco Energy Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mxc#NYSE">MXC</a>) fell 14.4% to close at $26.00 after jumping 22% on Monday.</li>
<li>Recon Technology, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rcon#NASDAQ">RCON</a>) dipped 14.3% to settle at $1.20.</li>
<li>PEDEVCO Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ped#NYSE">PED</a>) fell 10.9% to close at $1.80.</li>
<li>Atreca, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcel#NASDAQ">BCEL</a>) dipped 17.8% to close at $2.64.</li>
<li>TROOPS, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/troo#NASDAQ">TROO</a>) fell 14.7% to settle at $2.50.</li>
<li>AgriFORCE Growing Systems, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agri#NASDAQ">AGRI</a>) shares fell 14.4% to close at $2.50 after climbing 13% on Monday.</li>
<li>Owlet, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/owlt#NYSE">OWLT</a>) fell 10.9% to close at $2.50 after the company reported worse-than-expected Q4 EPS results.</li>
<li>Alector, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alec#NASDAQ">ALEC</a>) slipped 9.7% to settle at $13.41. Stifel downgraded Alector from Buy to Hold and lowered the price target from $32 to $18.</li>
</ul>

Comments

United States Antimony

매도 수량

United States Antimony (AMEX:UAMY) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌